XBiotech (XBIT) Stock Price, News & Analysis

Company Overview

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Key Stats

• Today's Range: $6.13 to $6.66
• 50-Day Range: $6.09 to $8.25
• 52-Week Range: $3.81 to $9.96
• Volume: 214,749 shs
• Average Volume: 76,925 shs
• Market Capitalization: $194.48 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

XBIT Stock Analysis - Frequently Asked Questions

How have XBIT shares performed this year?

XBiotech's stock was trading at $4.00 at the beginning of the year. Since then, XBIT stock has increased by 59.5% and is now trading at $6.38.
View the best growth stocks for 2024 here.

When did XBiotech IPO?

XBiotech (XBIT) raised $76 million in an IPO on Wednesday, April 15th 2015. The company issued 4,000,000 shares at a price of $18.00-$20.00 per share. WR Hambrecht + Co served as the underwriter for the IPO.

Who are XBiotech's major shareholders?

Top institutional shareholders of XBiotech include Geode Capital Management LLC (1.48%), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (0.83%), State Street Corp (0.74%) and Connor Clark & Lunn Investment Management Ltd. (0.25%).
View institutional ownership trends.

How do I buy shares of XBiotech?

Shares of XBIT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of XBiotech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that XBiotech investors own include Voyager Therapeutics (VYGR), American Water Works (AWK), The RMR Group (RMR), Waste Connections (WCN), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and AUO (AUOTY).

Company Calendar

• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:XBIT
• CUSIP: N/A
• CIK: 1626878
• Web: www.xbiotech.com
• Phone: (512) 386-2900
• Fax: 512-386-5505
• Employees: 100
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-24,560,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -15.99%
• Return on Assets: -14.85%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 11.57
• Quick Ratio: 11.57

Sales & Book Value

• Annual Sales: $4.01 million
• Price / Sales: 48.50
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $7.19 per share
• Price / Book: 0.89

Miscellaneous

• Outstanding Shares: 30,483,000
• Free Float: 20,393,000
• Market Cap: $194.48 million
• Optionable: Optionable
• Beta: 1.41